Robeco Institutional Asset Management B.V.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1418773
ROTTERDAM, P7
Position in BMRN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$23,358,062
-$7,436,614 QoQ
Shares Held
408,215
-25.1% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#71
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. BMRN ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
408,215 | $23,358,062 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,358,062 | 408,215 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $30,794,676 | 545,135 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $45,549,053 | 766,432 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $50,664,838 | 935,466 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $35,275,238 | 641,718 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $6,875,380 | 97,261 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $5,690,509 | 86,574 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $14,807,713 | 210,666 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $6,739,451 | 81,859 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $4,836,714 | 55,378 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $1,349,590 | 13,997 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,226,776 | 25,167 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,445,242 | 28,210 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $3,394,162 | 34,905 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $3,132,124 | 30,265 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $4,877,157 | 57,534 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $4,449,456 | 53,692 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $3,834,337 | 49,732 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $267,435 | 3,027 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $231,406 | 2,994 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $680,202 | 8,152 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $1,006,170 | 13,325 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $2,337,552 | 26,657 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $3,620,951 | 47,594 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $7,221,557 | 58,550 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $333,352 | 3,945 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||